Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Nice to see our Officers & Directors own Common Stock. CEO owns 43M shares alone. Also, the CEO & some directors have loaned the company money out of their own pockets to help this company succeed.
http://www.otcmarkets.com/edgar/GetFilingPdf?FilingID=11998298
Security Ownership of Management and Beneficial Owners, Shares of Common Stock Beneficially Owned, Percent of Common Stock Outstanding
Rik J. Deitsch Chief Executive Officer/President 43,219,275 12%
Dr. Stewart Lonky Director 4,755,450 1%
Harold Rumph Director 4,966,675 1%
Garry Pottruck Director 4,698,775 1%
Dan Oran 15,000,000 4%
All executive officers and directors as a group (5) persons 72,640,175 19%
Also, company has remained SEC compliant & will be OTCQB again once it breaks .01 & Rik submits the OTCQB Certification paperwork to OTC Markets. I believe the company will uplist eventually to OTCQX with partnership deal to bring in a larger pool of investors. JMO
Real product for sale, real revenue, no dilution, nice consolidation with every movement, long company history, 21 patents, REAL COMPANY!!! what more can you ask for in the sewers of otc land . Truly is a gem
Good morning FF, just an outstanding post as usual from you on how grossly undervalued NPHC currently is & the future potential of this company. Huge correction to Market Cap about to transpire. Copper a certainty & Silver as well with announcement of partnership deal & PHASE II trials going forward. Dilly Dilly!!!!
$NPHC
Interesting. I'll add this to my watchlist. Might grab a starter come Monday. I'll go all in if the CEO makes an announcement or filing at OTC Markets. Thanks for the info. GLTU
Has anyone been in contact with the CEO? This company has been dark for about a year now. Just curious why folks are posting news soon. I haven't seen anything on their Twitter page recently either. Thanks in advance.
Me too. The whales are starting to take notice & arriving in packs. Maybe, Moby will make an appearance? LOL
Have a good feeling we hear about some things this upcoming week! :)
Intellectual Property
Nutra Pharma seeks patent and other intellectual property rights to protect and preserve our proprietary technology and our right to capitalize on the results of our research and development activities. We also rely on trade secrets, know-how, continuing technological innovations and licensing opportunities to prove competitive advantages for our products in our markets and to develop new products.
Patents:
?
Nutra Pharma holds 21 patents in their portfolio. The following are the key patents that protect the Company's drugs for the treatment of viruses, autoimmune diseases and pain:
?
U.S. Patent No. 8,034,777, Modified Anticholinergic Neurotoxins as Modulators of the Autoimmune Reaction was granted in October 2011with 7 claims. The patent describes a method of treatment of a human patient suffering from Multiple Sclerosis comprising the administration of a disease-mitigating amount of a composition consisting of detoxified and modified alpha-cobratoxin in a saline solution. This patent is meant to protect and support our work in the production of drugs for the treatment of auto-immune diseases.
?
U.S. Patent No. 7,902,152, Use of cobratoxin as an analgesic was granted in March 2011 with 16 claims. The patent describes a composition of matter for an analgesic and its method of use is disclosed. The method of use is for the treatment of chronic pain, especially to the treatment of heretofore intractable pain as associated with advanced cancer. The pain associated with neurological conditions, rheumatoid arthritis, viral infections and lesions is also contemplated. The method includes administering to a host an alpha-neurotoxin that is characterized by its ability to blocking of the action of acetylcholine at nicotinic acetylcholine receptors. Currently, this would be applied to the Company's current and future drugs for the treatment of pain.
?
U.S. Patent No. 7,758,894, Modified elapid venoms as stimulators of the immune reaction was granted in July, 2010 with 14 claims. The patent describes a method of protection from infections by administering a detoxified and neurotropically active modified venom containing alpha-cobratoxin. Protection includes bacterial, viral and parasitic infections. This patent is meant to protect and support our work in our production of anti-infective treatments. Currently, this would be applied to RPI-MN and RPI-78.
$NPHC
I wonder if Rik is about to knock this out of the park next week with Partnership news & start of Phase II trials. Conversions have been done for weeks now & company currently cannot dilute any further due to the A/S being maxed out since last November. CEO amended the preferred shares back in late October but not the Common even though maxed out which tells me partnership deal is cometh. All retail trading going forward which will make the PPS fly & keep the shorts/flippers on edge without CD holders bailing them out. GLTA
$NPHC
Much much Better!!!
It was showing on LEVEL II. You won't see it when ETRF was showing 10K for sale at .0026. When ETRF wasn't on the ask lower than .0027 you could see it all day.
$NPHC
Good morning. Lets see if ETRF still has 14M shares to sell at .0027. Any news on Partnership & Phase II trials beginning & those shares will be bought up faster than hot cakes.
$NPHC
Nice close today. Lets get this trading above .003 tomorrow.
$NPHC
Today could be the last day to accumulate shares under .003.
$NPHC
Pumped up for the football games this afternoon. I'm from New England so a huge Pats fan. Tom Brady sure could use some Nyloxin for his hand he hurt in practice. lol
Go Pats!!!!!
Go NPHC!!!!
What is more probable is one of these companies partnering or buying us out.
I guess he didn't see the last PR which will help with revenues substantially. If the company can get its MS drug on the market this will be a billion dollar company instantly. The FDA has granted it orphan status & that is why this company is in a nice position for a partner or buyout. Time will tell. GLTU
$NPCH
I agree, it would be foolish to sell at these levels. Now, I don't have a bundle of shares like some of the folks on this board who have been accumulating since last year but I think my 3.5M shares will go a long way from these levels. Also, I'm still adding & bought some last week at .002 & .0027. : )
$NPHC
Very interesting that the company filed an amendment of the preferred shares & the creation of Series A preferred shares last October with the California SOS. Notice, they didn't increase the A/S of the common stock which is currently maxed out. Most stinky pinkies raise both especially when the A/S is maxed. This convinces me even further that a JV partner is coming aboard or possible merger with us being acquired from a big pharma. IMO - What are your thoughts on this filing? Thanks in advance.
https://businesssearch.sos.ca.gov/Document/RetrievePDF
https://businesssearch.sos.ca.gov/CBS/Detail
$NPHC
I'm expecting announcement soon of Partnership with another Bio company with deep pockets to begin Phase II trials.
Currently, Nutra Pharma offers several drug products for sale for the treatment of pain: Nyloxin®, the first over-the-counter (OTC) pain reliever clinically proven to treat moderate to severe (Stage 2) chronic pain, and Nyloxin Extra Strength, the only non-narcotic and non-addictive treatment for severe (Stage 3) pain. Nyloxin® is protected under patent #7,902,152, Use of cobratoxin as an analgesic. In December of 2014, the Company launched Pet Pain-Away - the first OTC product to treat pain in companion animals without side effects.
The Company is also developing proprietary therapeutic protein products primarily for the prevention and treatment of viral and neurological diseases, including Multiple Sclerosis (MS), Adrenomyeloneuropathy (AMN), Human Immunodeficiency Virus (HIV), and pain in humans. Nutra Pharma has completed pre-clinical and animal models for their MS and HIV applications and are preparing to move into pivotal Phase II trials. Nutra Pharma's MS drug was recently granted Orphan Status by the FDA for the treatment of Pediatric Multiple Sclerosis. .
http://www.nutrapharma.com/
$NPHC
Nice post as always Fly. I've been averaging up since it broke .001. Still dirt cheap at these levels. Buyers regret soon for some when they had the opportunity to load at these levels. Expecting multiple pennies here. Enjoy your weekend.
$NPHC
Makes sense. Still have to cover if naked or borrowed shares.
Why so many 100 trades? Commission costs more. Lol
All those 100 trades. Hmmmmm lol - MM trying to cover with each other. Good luck. No more sellers left. Bring the news of partnership & phase II trials.
$NPHC
I added at .002. I also added yesterday at .0027. Great news yesterday. This should be trading much higher.
Wow!!!! That is awesome news!!!!!
$NPHC
Crazy this stock is so cheap. I grabbed 650K shares at .0017 today. Holding for copper. GLTU
$NPHC
My guess is he retired the 1.2B shares & received preferred shares in exchange in order to reduce the A/S to 900M. The A/S has been reduced at the Nevada SOS & verified by the TA from another poster but the R/S hasn't been approved yet by FINRA. CEO needs to speak up Monday morning or the blood bath continues & the R/S will have no impact. GLTA
Giuseppe Gentile: (Control Person) 1,215,280,000 RESTRICTED, equaling 56% control. 2 Wall Street, New York, NY Gary Molinaro: President (Beneficial Owner) 18 million Preferred Shares equaling 90%, 334 Cornelia Street Suite 236 Plattsburgh, NY 12901
How could they reduce the A/S to 900M when they had 2.1B shares O/S as of 31 Aug according to their last filing? They would have to retire 1.2B shares before reducing the A/S. Since, the R/S has not taken place yet until FINRA approves it, the company had to retire shares for this to be legit. The CEO needs to clarify with investors the new business model, recapitalization, & reorganization of the previous shell to Fansfrenzy Corp.. Nevada SOS confirms 900M A/S as well. I believe they retired those shares but are also trying to do the R/S according to the filing at Nevada. Need the CEO to speak up about the new business model & possible partners. This PPS drop of 75% is appears to be a great buying opportunity but won't know until we get news. GLTA
http://www.otcmarkets.com/financialReportViewer?symbol=HRRN&id=180787
EXACTLY! I phoned the TA (see my posting history) who confirmed the company has REDUCED the Authorised Share Count to 900m!
Phone up for yourselves folks and have a chat. They will confirm what they said to me.
The O/S increased over 200M shares from beginning of October. Once, the conversions are sold completely into the float this will run bigly as long as the company doesn't raise the A/S or do a R/S any time soon. The conversions should be coming to an end soon. IMO
BTW - I grabbed a starter position the past few days. Huge potential here. Could run to multiple pennies with their drug pipeline & patents.
$NPHC
My first buy was at .0051 & have been DCA all the way from those levels to my last purchase at .0026. Put a bid in late Friday at .0025 which didn't get executed but will probably on Monday. Just need one Government or State contract for their PSS & this will be trading multiple pennies instantly. Just need that first contract signed & distributors will follow. GLTU
$DTII
When is the company actually going to sell a single scanner & find a distributor to sell many? What is the holdup?
DTII
It appears UBQU has strong support at .006. Dilution has definitely ceased for the time being. Now, is the time for Jimmy to release the robust news shareholders have been anticipating since Labor Day. Time will tell if a correction is about to transpire.
To bad UBQU is a Software company. Looking forward to that robust news after Labor Day. Maybe, Jimbo was confused & meant Columbus Day. lol
UBQU - New 52-week low coming soon.
Twitter followers means nothing to me as far as I'm concerned. How about they get their financials audited. Have you looked into their current CPA? You might not like what you find or don't find for that matter. Lol
BTW - The Name change to HLT & a new loan with better terms to eliminate the old notes would have been a game changer as far as I'm concerned. This stock could have went to .50 to $1 even with their unaudited financials. If they would have upgraded to the OTCQX which requires Audited financials with the SEC this could have seen multiple dollars. It also demonstrates the company is legit to investors. But, Ballas couldn't execute & continues to display he doesn't care for his shareholders. He does care about his Note Holders though. This stock acts just like every other stinky pinky. How long before they raise the A/S or do a R/S? My prediction is by next summer.
I wasn't predicting anything with Cryptobuy because it hasn't even started up yet. Facts are zero revenues from Cryptobuy as of today. Tell James if he needs a loan I'll convert at .002 instead of .001.
I don't have to spoil anything. The stock actually performs better without news. Whenever news is released the PPS usually has a temporary spike before crashing by end of day due to dilution. The Note Holders love news because it usually brings in more liquidity to the stock. I'm patiently waiting for .001 - .002 before I buy again. GLTU & hope I'm wrong on my prediction for shareholders sake. You guys have suffered enough already. Enjoy your weekend!!!!
Does anyone know who owns the 1M Preferred Shares that are Outstanding? They were initially issued to Mr. Change but canceled. I cannot find anything in the financials stating who owns the Preferred Shares. This is key for shareholders if you actually have a meaningful vote or not on Company changes.
The Company issued 1,000,000 preferred convertible shares to Mr. Chang, the Company’s former President and CEO, as part of his compensation package on February 1, 2013. The issuance of these convertible shares was subsequently canceled. On April 15, 2014 Chih-Wei Chang assigned 8,500,000 shares of common stock to Blue Crush Marketing Group pursuant to an acquisition agreement which became effective on that same day. These shares were then returned to treasury
NOPE!!!! This is not a one Division company and that is why I am here!! As I said before the smartest decision they did.
He needs to give people a reason to have faith. Fixing the relationship with shareholders should be a priority for the company.
It will be a while before all the notes are paid off. They still have $700K to convert at .001, not counting if any new notes have been established for the PET MED products & crypto B.S.. They will have to raise the A/S or do a R/S to convert the remaining balance. Why doesn't Ballas refinance the loan for better terms so he can pay off those two note holders who have already made millions off their investment?
(10) Notes Payable As of May 31, 2017, the company had $696,516 of long term debt. $281,692 of this debt is owed to R Holdings 9 originally dated August 30, 2011, representing money advanced to James Ballas, the company president, Blue Crush Marketing Group and or its subsidiaries. $403,814 of this debt in the form of several notes originally dated during 2013 and 2014 are owed to Common Sense Holdings, LLC representing money advanced to James Ballas, the company president, during the period covering September 1, 2013 to August 31, 2014 for expenses of the company. The Promissory Notes provide for interest at rates between 8% and 10% per annum that are payable on maturity dates in 2017 and 2018. These notes contain a conversion features whereby the notes are convertible in whole or in part, at the sole discretion of the holder, into shares of common stock at a conversion price of $.001 per share or the company “par” value.